Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

ORGANON PHARMA PTY LTD

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (147)
Cancellation by sponsor (18)

Date

2024 (1)
2023 (19)
2022 (5)
2021 (2)
2020 (1)
2019 (2)
2017 (1)
2016 (14)
2015 (20)
2014 (1)
2013 (21)
2012 (4)
2011 (2)
2010 (6)
2008 (2)
2007 (3)
2006 (5)
2005 (9)
2003 (1)
2002 (3)
2001 (8)
2000 (2)
1999 (5)
1998 (5)
1997 (4)
1996 (1)
1995 (1)
1993 (2)
1992 (4)
1991 (11)

Results for "[search-keyword]"

Search

Sponsor content

165 result(s) found, displaying 11 to 20

MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack (407853)

18 April 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack.
LARCPLANON etonogestrel 68mg subcutaneous implant blister pack (395528)

22 February 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LARCPLANON etonogestrel 68mg subcutaneous implant blister pack.
JULESTREL etonogestrel 68mg subcutaneous implant blister pack (395527)

22 February 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for JULESTREL etonogestrel 68mg subcutaneous implant blister pack.
OLMESARTAN/ AMLODIPINE - DSK 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 20/5 olmesartan medoxomil 20 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
NUVARING etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
PREGNYL gonadotrophin - chorionic human 1500IU powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
PREGNYL gonadotrophin - chorionic human 5000IU powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
SINEMET CR levodopa/carbidopa 200 mg/50 mg modified release tablet bottle Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.